| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Atherogenic lipoproteins and diabetes mellitus
|
Yoshino, Gen
|
|
2002
|
16 |
1 |
p. 29-34
6 p.
|
artikel
|
| 2 |
CD36, serves as a receptor for advanced glycation endproducts (AGE)
|
Ohgami, Nobutaka
|
|
2002
|
16 |
1 |
p. 56-59
4 p.
|
artikel
|
| 3 |
Clinical implication of multiple risk factor control in the management of diabetic macrovasucular complications
|
Suzuki, M
|
|
2002
|
16 |
1 |
p. 115-118
4 p.
|
artikel
|
| 4 |
Hexosamines as mediators of nutrient sensing and regulation in diabetes
|
McClain, Donald A.
|
|
2002
|
16 |
1 |
p. 72-80
9 p.
|
artikel
|
| 5 |
Hyperglycemia-induced alteration of vascular smooth muscle phenotype
|
Mori, Seijiro
|
|
2002
|
16 |
1 |
p. 65-68
4 p.
|
artikel
|
| 6 |
Impact of insulin resistance on neointimal tissue proliferation after coronary stent implantation
|
Takagi, Tsutomu
|
|
2002
|
16 |
1 |
p. 50-55
6 p.
|
artikel
|
| 7 |
Importance of blood pressure control in patients with diabetes mellitus
|
Katayama, Shigehiro
|
|
2002
|
16 |
1 |
p. 87-91
5 p.
|
artikel
|
| 8 |
Influence of insulin and of insulin resistance on platelet and vascular smooth muscle cell function
|
Trovati, Mariella
|
|
2002
|
16 |
1 |
p. 35-40
6 p.
|
artikel
|
| 9 |
Insulin resistance and vascular function
|
Baron, Alain D.
|
|
2002
|
16 |
1 |
p. 92-102
11 p.
|
artikel
|
| 10 |
Introduction for the international symposium on insulin resistance and atherosclerosis
|
|
|
2002
|
16 |
1 |
p. 1-
1 p.
|
artikel
|
| 11 |
Lysophosphatidylcholine inhibits the expression of prostacyclin stimulating factor in cultured vascular smooth muscle cells
|
Hashimoto, Toshihiko
|
|
2002
|
16 |
1 |
p. 81-86
6 p.
|
artikel
|
| 12 |
Macrovascular disease risk factors and insulin resistance in Aboriginal and Torres Strait Islander people
|
O'Dea, Kerin
|
|
2002
|
16 |
1 |
p. 9-16
8 p.
|
artikel
|
| 13 |
Molecular mechanism of vascular disease in metabolic syndrome X
|
Matsuzawa, Yuji
|
|
2002
|
16 |
1 |
p. 17-18
2 p.
|
artikel
|
| 14 |
Multifactorial insulin resistance and clinical impact in hypertension and cardiovascular diseases
|
Harano, Yutaka
|
|
2002
|
16 |
1 |
p. 19-23
5 p.
|
artikel
|
| 15 |
Pathophysiogical role of leptin in lifestyle-related diseases
|
Ogawa, Yoshihiro
|
|
2002
|
16 |
1 |
p. 119-122
4 p.
|
artikel
|
| 16 |
Pathophysiological role of oxidized low-density lipoprotein in plaque instability in coronary artery diseases
|
Ehara, Shoichi
|
|
2002
|
16 |
1 |
p. 60-64
5 p.
|
artikel
|
| 17 |
Renal endothelial dysfunction and hypertension
|
Higashi, Yukihito
|
|
2002
|
16 |
1 |
p. 103-107
5 p.
|
artikel
|
| 18 |
Role of glycogen synthase kinase-3 in skeletal muscle insulin resistance in Type 2 diabetes
|
Ciaraldi, T.P
|
|
2002
|
16 |
1 |
p. 69-71
3 p.
|
artikel
|
| 19 |
Roles of peroxisome proliferator-activated receptor γ in cardiovascular disease
|
Takano, Hiroyuki
|
|
2002
|
16 |
1 |
p. 108-114
7 p.
|
artikel
|
| 20 |
The family of protein kinase C and membrane lipid mediators
|
Saito, Naoaki
|
|
2002
|
16 |
1 |
p. 4-8
5 p.
|
artikel
|
| 21 |
The mechanism of HDL lowering in hypertriglyceridemic, insulin-resistant states
|
Rashid, Shirya
|
|
2002
|
16 |
1 |
p. 24-28
5 p.
|
artikel
|
| 22 |
The pathophysiologic basis of efficacy and clinical experience with the new oral antidiabetic agents
|
Rosak, Christoph
|
|
2002
|
16 |
1 |
p. 123-132
10 p.
|
artikel
|
| 23 |
The role of PPARγ in high-fat diet-induced obesity and insulin resistance
|
Kadowaki, Takashi
|
|
2002
|
16 |
1 |
p. 41-45
5 p.
|
artikel
|
| 24 |
Vascular protective effects by activation of nuclear receptor PPARγ
|
Wakino, Shu
|
|
2002
|
16 |
1 |
p. 46-49
4 p.
|
artikel
|
Tijdschrift beschrijving